Trial Profile
Investigation of effect of imatinib on bone marrow fibrosis in patients with chronic myeloid leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jan 2016
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia; Myelofibrosis
- Focus Therapeutic Use
- 22 Jan 2016 New trial record
- 08 Dec 2015 Results of retrospective study presented at the 57th Annual Meeting and Exposition of the American Society of Hematology